FTSE 100 slipped 10 points to 10,479 as AstraZeneca tumbled following a clinical trial failure. Gains elsewhere were offset by company-specific negatives, with Computacenter and Playtech rising on trading updates. Net effect is a mildly risk-off session driven primarily by AstraZeneca’s trial outcome.
FTSE 100 slipped 10 points to 10,479 as AstraZeneca tumbled following a clinical trial failure. Gains elsewhere were offset by company-specific negatives, with Computacenter and Playtech rising on trading updates. Net effect is a mildly risk-off session driven primarily by AstraZeneca’s trial outcome.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
moderately negative
Sentiment Score
-0.45
Ticker Sentiment
